Hepatitis B Virus X Protein Induces Hepatic Steatosis Via Transcriptional Activation of SREBP1 and PPARγ

Gastroenterology

Volumn 132, Issue 5, 2007, Pages 1955-1967

  Kim, Kook Hwan ^a   Shin, Hye Jun ^b   Kim, Kyeongjin ^a   Choi, Hyun Mi ^a   Rhee, Sang Hoon ^c   Moon, Hyung Bae ^d   Kim, Hyeong Hoe ^e   Yang, Ung Suk ^f   Yu, Dae Yeul ^b   Cheong, Jaehun ^a  

^a Pusan National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Wonkwang University   (South Korea)

^e Pusan National University School of Medicine   (South Korea)

^f Bong Seng Memorial Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEPATITIS; LIPID METABOLISM; LIPID STORAGE; LIVER CANCER; LIVER CELL; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 34247637220     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.03.039     Document Type: Article

References (59)

1. Lok A.S. Chronic hepatitis B. N Engl J Med 346 (2002) 1682-1683
2. Gordon A., McLean C.A., Pedersen J.S., Bailey M.J., and Roberts S.K. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol 43 (2005) 38-44
3. Powell E.E., Jonsson J.R., and Clouston A.D. Steatosis: co-factor in other liver diseases. Hepatology 42 (2005) 5-13
4. Ohata K., Hamasaki K., Toriyama K., Matsumoto K., Saeki A., Yanagi K., Abiru S., Nakagawa Y., Shigeno M., Miyazoe S., Ichikawa T., Ishikawa H., Nakao K., and Eguchi K. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97 (2003) 3036-3043
5. Hajjou M., Norel R., Carver R., Marion P., Cullen J., Rogler L.E., and Rogler C.E. cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J Med Virol 77 (2005) 57-65
6. Kang S.K., Chung T.W., Lee J.Y., Lee Y.C., Morton R.E., and Kim C.H. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J Biol Chem 279 (2004) 28106-28112
7. Yokoyama C., Wang X., Briggs M.R., Admon A., Wu J., Hua X., Goldstein J.L., and Brown M.S. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75 (1993) 187-197
8. Goldstein J.L., and Brown M.S. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997) 331-340
9. Wang X., Sato R., Brown M.S., Hua X., and Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77 (1994) 53-62
10. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., and Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99 (1997) 846-854
11. Tontonoz P., Hu E., Graves R.A., Budavari A.I., and Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8 (1994) 1224-1234
12. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
13. Gavrilova O., Haluzik M., Matsusue K., Cutson J.J., Johnson L., Dietz K.R., Nicol C.J., Vinson C., Gonzalez F.J., and Reitman M.L. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278 (2003) 34268-34276
14. Yu S., Matsusue K., Kashireddy P., Cao W.Q., Yeldandi V., Yeldandi A.V., Rao M.S., Gonzalez F.J., and Reddy J.K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 278 (2003) 498-505
15. Schadinger S.E., Bucher N.L., Schreiber B.M., and Farmer S.R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol 288 (2005) E1195-E1205
16. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., and Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273 (1998) 5678-5684
17. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103 (1999) 1489-1498
18. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96 (1999) 7473-7478
19. Yu D.Y., Moon H.B., Son J.K., Jeong S., Yu S.L., Yoon H., Han Y.M., Lee C.S., Park J.S., Lee C.H., Hyun B.H., Murakami S., and Lee K.K. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 31 (1999) 123-132
20. Toth J.I., Datta S., Athanikar J.N., Freedman L.P., and Osborne T.F. Selective coactivator interactions in gene activation by SREBP-1a and -1c. Mol Cell Biol 24 (2004) 8288-8300
21. Bennett M.K., Lopez J.M., Sanchez H.B., and Osborne T.F. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J Biol Chem 270 (1995) 25578-25583
22. Kong H.J., Park M.J., Hong S., Yu H.J., Lee Y.C., Choi Y.H., and Cheong J. Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2. Hepatology 38 (2003) 1258-1266
23. Hong S., Park S.J., Kong H.J., Shuman J.D., and Cheong J. Functional interaction of bZIP proteins and the large subunit of replication factor C in liver and adipose cells. J Biol Chem 276 (2001) 28098-28105
24. Lee M.Y., Kong H.J., and Cheong J. Regulation of activating transcription factor-2 in early stage of the adipocyte differentiation program. Biochem Biophys Res Commun 281 (2001) 1241-1247
25. Frith C.H., and Ward J.M. A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J Environ Pathol Toxicol 3 (1979) 329-351
26. Fleischmann M., and Iynedjian P.B. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem J 349 (2000) 13-17
27. Ono H., Shimano H., Katagiri H., Yahagi N., Sakoda H., Onishi Y., Anai M., Ogihara T., Fujishiro M., Viana A.Y., Fukushima Y., Abe M., Shojima N., Kikuchi M., Yamada N., Oka Y., and Asano T. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52 (2003) 2905-2913
28. Lee Y.I., Kang-Park S., Do S.I., and Lee Y.I. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 276 (2001) 16969-16977
29. Horie Y., Suzuki A., Kataoka E., Sasaki T., Hamada K., Sasaki J., Mizuno K., Hasegawa G., Kishimoto H., Iizuka M., Naito M., Enomoto K., Watanabe S., Mak T.W., and Nakano T. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113 (2004) 1774-1783
30. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., and Spiegelman B.M. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16 (2002) 22-26
31. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114 (2004) 147-152
32. Kaserer K., Fiedler R., Steindl P., Muller C.H., Wrba F., and Ferenci P. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology 32 (1998) 454-461
33. Giannini E., Ceppa P., and Testa R. Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy?. J Hepatol 35 (2001) 432-433
34. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 36 (2001) 651-660
35. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108 (2001) 1167-1174
36. Chang Y., Wang J., Lu X., Thewke D.P., and Mason R.J. KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 46 (2005) 2624-2635
37. Kotzka J., Muller-Wieland D., Koponen A., Njamen D., Kremer L., Roth G., Munck M., Knebel B., and Krone W. ADD1/SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathway. Biochem Biophys Res Commun 249 (1998) 375-379
38. Cha M.Y., Kim C.M., Park Y.M., and Ryu W.S. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Hepatology 39 (2004) 1683-1693
39. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
40. Kim K.H., Song M.J., Yoo E.J., Choe S.S., Park S.D., and Kim J.B. Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J Biol Chem 279 (2004) 51999-52006
41. Hensley K., Kotake Y., Sang H., Pye Q.N., Wallis G.L., Kolker L.M., Tabatabaie T., Stewart C.A., Konishi Y., Nakae D., and Floyd R.A. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 21 (2000) 983-989
42. Oliveira C.P., da Costa Gayotto L.C., Tatai C., Della Bina B.I., Janiszew-ski M., Lima E.S., Abdalla D.S., Lopasso F.P., Laurindo F.R., and Laudanna A.A. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med 6 (2002) 399-406
43. Lieber C.S. CYP2E1: from ASH to NASH. Hepatol Res 28 (2004) 1-11
44. Seki S., Kitada T., Yamada T., Sakaguchi H., Nakatani K., and Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37 (2002) 56-62
45. Yang S., Zhu H., Li Y., Lin H., Gabrielson K., Trush M.A., and Diehl A.M. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 378 (2000) 259-268
46. Waris G., Huh K.W., and Siddiqui A.R. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 21 (2001) 7721-7730
47. Shirakata Y., and Koike K. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem 278 (2003) 22071-22078
48. Lee Y.I., Hwang J.M., Im J.H., Lee Y.I., Kim N.S., Kim D.G., Yu D.Y., Moon H.B., and Park S.K. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem 279 (2004) 15460-15471
49. Lee M.O., Choi Y.H., Shin E.C., Kang H.J., Kim Y.M., Jeong S.Y., Seong J.K., Yu D.Y., Cho H., Park J.H., and Kim S.J. Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. J Hepatol 37 (2002) 380-386
50. Dharancy S., Malapel M., Perlemuter G., Roskams T., Cheng Y., Dubuquoy L., Podevin P., Conti F., Canva V., Philippe D., Gambiez L., Mathurin P., Paris J.C., Schoonjans K., Calmus Y., Pol S., Auwerx J., and Desreumaux P. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 128 (2005) 334-342
51. Huan B., Kosovsky M.J., and Siddiqui A. Retinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J Virol 69 (1995) 547-551
52. Guidotti L.G., Eggers C.M., Raney A.K., Chi S.Y., Peters J.M., Gonzalez F.J., and McLachlan A. In vivo regulation of hepatitis B virus replication by peroxisome proliferators. J Virol 73 (1999) 10377-10386
53. Yu X., and Mertz J.E. Critical roles of nuclear receptor response elements in replication of hepatitis B virus. J Virol 75 (2001) 11354-11364
54. Yaginuma K., Shirakata Y., Kobayashi M., and Koike K. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A 84 (1987) 2678-2682
55. Bouchard M.J., Wang L.H., and Schneider R.J. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294 (2001) 2376-2378
56. Zhang Z., Protzer U., Hu Z., Jacob J., and Liang T.J. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol 78 (2004) 4566-4572
57. Xu Z., Yen T.S., Wu L., Madden C.R., Tan W., Slagle B.L., and Ou J.H. Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol 76 (2002) 2579-2584
58. Keasler V.V., Hodgson A.J., Madden C.R., and Slagle B.L. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol (2006) [Epub ahead of print]
59. de Gottardi A., Pazienza V., Pugnale P., Bruttin F., Rubbia-Brandt L., Juge-Aubry C.E., Meier C.A., Hadengue A., and Negro F. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection. Aliment Pharmacol Ther 23 (2006) 107-114